| Literature DB >> 35366116 |
Jie Wei1, Xue Zhou1, Mei Dong1, Lufan Yang1, Cheng Zhao1, Ruili Lu2, Guanhu Bao3, Fenglin Hu4.
Abstract
High-resolution mass spectrometry (HRMS) and nuclear magnetic resonance (NMR) analysis revealed that there are 20 main components in spores and mycelia extract of Cordyceps fumosorosea strain RCEF 6672 including mannitol (1), uridine (2), adenine (3). N6-(2-hydroxyethyl)-adenosine (4). N6-(2-hydroxyethylacetate)-adenosine (5), fumosoroseanoside A (6) and B (7), ovalicin-4α-alcohol (8), 1-linoleoyl-sn-glycero-3-phosphocholine (9) and its isomer (10), fumosoroseain A (11) and its isomer (12), 5 non-ribosomal peptides (13 to 17) and 3 fatty acids (18 to 20). The compounds 5, 6, 7, 9 and 11 were prepared with preparative and semi-preparative HPLC and identified with 1D and 2D NMR. Compounds 4 and 5 were the first time identified from C. fumosorosea. Compounds 6, 7 and 11 are novel compounds. Compounds 6 and 7 showed antibacterial and antifungal activities, and 11 showed antiaging activity. All the secondary metabolites (4 to 8 and 11 to 17) have strong bioactivities indicating that the metabolites have pharmaceutical development potentiality.Entities:
Keywords: Antiaging; Antibacterial; Antifungal; Cordyceps fumosorosea; Fumosoroseain; Fumosoroseanosides
Year: 2022 PMID: 35366116 PMCID: PMC8976864 DOI: 10.1186/s13568-022-01379-w
Source DB: PubMed Journal: AMB Express ISSN: 2191-0855 Impact factor: 3.298
Fig. 1HPLC-HRMS analysis of the extract form spores and mycelia of Cordyceps fumosorosea. A is the base peak chromatogram of the crude extract in positive model; B is the base peak chromatogram of the crude extract in negative model; number 5, 6, 7, 9 and 11 are the five possible unknown metabolites, and ‘ + ’, ‘ − ’, ‘U’ and ‘ECD’ mean cation, anion, ultraviolet spectrum and circular dichroism of the metabolites respectively
Main metabolites of extract form spores and mycelia of Cordyceps fumosorosea
| Retention time (min) (Number) | Mass (m/z) and erro (mDa) | Uvλmax (nm) | Molecular formula | Name |
|---|---|---|---|---|
| 1.66 (1) | [M−H]−181.0729, 1.1 | 200 | C6H14O6 | Mannitola |
| 4.83 (2) | [M−H]− 243.0625, 0.2; [2 M−H]− 487.1321, 0.3 [M + H]+ 245.0763, 0.5; [M-C5H7O4]+113.0349, 0.3 | 206, 261 | C9H12N2O6 | Uridinea |
| 9.74 (3) | [M-H]− 266.0899, 0.4; [M-C5H9O4]− 134.0476, 0.4 [M + H]+ 268.1045, 0.5; [M-C5H7O4]+136.0822, 0.6 | 205, 258 | C10H13N5O4 | Adeninea |
| 14.13 (4) | [M−H]− 310.1155, 0.2; [M-C5H9O4]− 178.0731, 0.3 [M + H]+ 312.1305, 0.3; [M-C5H7O4]+180.0876, 0.4 | 209, 265 | C12H17N5O5 | N6-(2-Hydroxyethyl)-Adenosinea |
| 16.41 (5) | [M−H]− 352.1266, 0.3; [M-C5H9O4]− 220.0839, 0.1 [M + H]+ 354.1410, 0.2; [M-C5H7O4]+ 222.0979, 0.7 | 209, 265 | C14H19N5O6 | Unknown |
| 22.24 (6) | [M−H]− 491.1565, 0.6; [M + H]+ 493.1699, 0.5 | 262, 361 | C24H28O11 | Unknown |
| 22.43 (7) | [M−H]− 507.1513, 0.5; [M + H]+ 509.1658, 0.4 | 262, 361 | C24H28O12 | Unknown |
| 28.85 (8) | [M−H]− 297.1718, 1.1; [M + H]+ 299.1859, 0.6; [M + Na]+ 321.1680, 0.8 | 200 | C16H26O5 | Ovalicin-4α-alcohol |
32.41 (9) 32.88 (10) | [M−H]− 476.2785, 0.2; [M + H]+ 478.2928, 0; [M + Na]+ 500.2744, 0.4 | 200 | C23H44NO7P | Unknown |
34.28 (11) 34.83 (12) | [M + COOH]− 542.3695, 0.3; [M + H]+ 498.3791, 0.2; [M-C18H29O]+ 236.1495, 0.3 | 200 | C28H51NO6 | Unknown |
| 35.94 (13) | [M−H]− 486.2863, 0.5; [M + H]+ 488.3010, 0.7 | 215 | C27H41N3O5 | Beauveriolide Ib |
| 38.36 (14) | [M−H]− 734.4031, 0.9; [M + H]+ 736.4173, 0.5; [M + NH4]+ 753.4438, 0.5; [M + Na]+ 758.3985, 0.2 | 210 | C41H57N3O9 | Beauveriolide E |
| 39.06 (15) | [M-H]− 782.4039, 0.7; [M + H]+ 784.4171, 0.3; [M + NH4]+ 801.4439, 0.6; [M + Na]+ 806.3991, 0.4 | 255 | C45H57N3O9 | Beauvericinb |
| 39.45 (16) | [M-H]− 804.3469, 0.8; [M + H]+ 806.3612, 0.5 | 225, 280 | C41H51N5O12 | Conoideocrellide D |
| 39.92 (17) | [M−H]− 796.4185, 0.6; [M + H]+ 798.4331, 0.7; [M + NH4]+ 815.465, 0.6; [M + Na]+ 820.4138, 0.8 | 260 | C46H59N3O9 | Beauvericin Aa |
| 41.69 (18) | [M−H]− 279.2332, 0.2; [M + H]+ 281.2469, 0.6 | 200 | C18H32O2 | Linoleic acid |
| 43.21 (19) | [M−H]− 255.2334, 0.4; [M + H]+ 257.2473, 0.2 | 200 | C16H32O2 | Palmitic acid |
| 43.54 (20) | [M−H]− 281.2481, 0.5; [M + H]+ 283.2629, 0.3 | 200 | C18H34O2 | Oleic acid |
aConfirmed with standards
bHave been reported from Cordyceps fumosorosea, Isaria fumosorosea or Paecilomyces fumosoroseus 33–35
Fig. 2Structures of compounds 5, 6, 7, 9 and 11, and HMBC and 1H-1H COSY correlations of the compounds 6, 7 and 11
1D and 2D NMR spectral data (δ in ppm) of compound 5
| Position | 13C | DEPT, HMQC | δH, mult (J in Hz) | 1H,1H-COSY | HMBC |
|---|---|---|---|---|---|
| 2 | 152.1 | CH | 8.19, br | ||
| 4 | 148.0 | C | |||
| 5 | 120.2 | C | |||
| 6 | 155.0 | C | |||
| 8 | 140.3 | CH | 8.23, s | ||
| 1′ | 39.1 | CH2 | 3.84, m | 4.27 | |
| 2′ | 62.7 | CH2 | 4.27, t (5.4) | ||
| 3′ | 171.5 | C | |||
| 4′ | 19.4 | CH3 | 2.00, s | 171.5 | |
| 1″ | 89.9 | CH | 5.93, d (6.4) | 4.71 | 74.1, 140.3, 148.0 |
| 2″ | 74.1 | CH | 4.71, dd (6.4, 5.1) | 4.30, 5.93 | 89.9 |
| 3″ | 71.3 | CH | 4.30, dd (5.1, 2.7) | 4.71, 4.14 | 62.2, 89.9 |
| 4″ | 86.9 | CH | 4.14, q (2.6) | 3.71, 3.85, 4.30 | 71.3 |
| 5″ | 62.2 | CH2 | 3.71, dd (12.5, 2.7); 3.85 dd (12.5, 2.7) | 3.85, 4.14; 3.71, 4.14 | 71.3, 86.9 |
1D and 2D NMR spectral data (δ in ppm) of compound 6, and 1H and 13C NMR spectral data of compound 7
| Compound | Compound 7 | ||||||
|---|---|---|---|---|---|---|---|
| Position | 13C | DEPT135, HMQC | δH, mult (J in Hz) | 1H,1H-COSY | HMBC | 13C | δH, mult (J in Hz) |
| 1 | 170.4 | C | 170.5 | ||||
| 3 | 75.3 | CH | 4.97, m | 2.96, 3.04; 2.91, 2.98 | 75.1 | 4.86, m | |
| 4 | 32.6 | CH2 | 2.96, m; 3.04, m | 2.96, 3.04, 4.97 | 134.7 | 33.1 | 3.00, m; 3.03, m |
| 4a | 134.7 | C | 134.6 | ||||
| 5 | 115.6 | CH | 6.97, s | 100.9, 110.3, 32.6, 140.9 | 115.5 | 6.88, s | |
| 5a | 140.9 | C | 140.9 | ||||
| 6 | 100.9 | CH | 6.84, d (2.3) | 6.74 | 110.3, 115.6, 102.0, 161.6 | 100.9 | 6.82, d (2.3) |
| 7 | 158.1 | C | 158.1 | ||||
| 8 | 102 | CH | 6.74, d(2.2) | 6.84 | 110.3, 161.6, 158.1, 101.2 | 102 | 6.72, d (2.2) |
| 9 | 161.6 | C | 161.6 | ||||
| 9a | 110.3 | C | 110.3 | ||||
| 10 | 163.4 | C | 163.4 | ||||
| 10a | 101.3 | C | 101.3 | ||||
| 11 | 47.7 | CH2 | 2.91, dd(17.1, 5.2); 2.98, dd (17.2, 7.3) | 2.91, 2.98, 4.97 | 205.5, 75.3 | 40.6 | 2.79, dd (16.1, 8.1), 2.88, dd (16.1, 4.3) |
| 12 | 205.5 | C | 170.4 | ||||
| 13(R) | 30.6 | CH3 | 2.14, s | 205.5, 47.7 | 52.2 | 3.63, s | |
| 14 | 56.0 | CH3 | 3.83, s | 56.1 | 3.80, s | ||
| 1′ | 101.2 | CH | 4.99, d (7.2) | 3.38 | 158.1 | 101.2 | 4.99, d (7.2) |
| 2′ | 74 | CH | 3.38, m | 4.99, 5.23, 3.42 | 101.2 | 74 | 3.38, m |
| 3′ | 76.2 | CH | 3.42, m | 3.02, 3.38 | 76.2 | 3.42, m | |
| 4′ | 79.4 | CH | 3.02, m | 3.41, 3.42 | 76.2, 76.5 | 79.4 | 3.02, m |
| 5′ | 76.5 | CH | 3.41, m | 3.02 | 76.5 | 3.41, m | |
| 6′ | 60.6 | CH2 | 3.48, m; 3.62, m | 3.48, 3.62, 3.42, 4.71 | 60.6 | 3.48, m; 3.62, m | |
| 7′ | 60.0 | CH3 | 3.43, s | 79.4 | 60.0 | 3.43, s | |
| OH | 3.3 | ||||||
| OH | 4.71 | 3.48, 3.62 | |||||
| OH | 5.23 | 3.38 | |||||
| OH | 8.35 | ||||||
1D and 2D NMR spectral data (δ in ppm) of compound 9
| Position | 13C | DEPT, HMQC | δH, mult (J in Hz) | COSY | HMBC |
|---|---|---|---|---|---|
| 1 | 66.23 | CH2 | 4.13, dd (11.3, 6.1); | 4.20; 4.00 | 175.41, 69.9 |
| 4.20, dd (11.3, 4.6) | 4.13; 4.00 | ||||
| 2 | 69.90 (d, J = 7.5) | CH | 4.00, quint (5.3) | 3.92 | 67.80, 66.23 |
| 3 | 67.80 (d, J = 5.7) | CH2 | 3.92, m | 4.0 | 68.54 |
| 1′ | 175.41 | C | |||
| 2′ | 34.93 | CH2 | 2.38, t (7.5) | 1.65 | 26.0 |
| 3′ | 26.0 | CH2 | 1.65, m | 2.38; 1.36 | 34.93 |
| 4′ | 30.23 | CH2 | 1.34–1.37 | 1.65 | 26.0–30.48 |
| 5′ | 30.24 | CH2 | |||
| 6′ | 30.32 | CH2 | |||
| 7′ | 30.48 | CH2 | |||
| 8′ | 28.17 | CH2 | 2.09, dd (13.17, 6.37) | 1.39; 5.39 | 130.87 |
| 9′ | 130.87 | CH | 5.39, m | 2.09 | 28.17 |
| 10′ | 129.13 | CH | 5.33, m | 2.80 | 26.56 |
| 11′ | 26.56 | CH2 | 2.80, t (6.3) | 5.33 | 129.07, 129.13 |
| 12′ | 129.07 | CH | 5.33, m | 2.76 | 25.56 |
| 13′ | 130.96 | CH | 5.39, m | 2.09 | 27.17 |
| 14′ | 28.17 | CH2 | 2.09, dd (13.17, 6.37) | 1.39; 5.39 | 130.96 |
| 15′ | 30.74 | CH2 | 1.34–1.37 | ||
| 16′ | 32.64 | CH2 | |||
| 17′ | 23.60 | CH2 | 1.33, m | 0.93 | 14.45 |
| 18′ | 14.45 | CH3 | 0.93, t (6.7) | 1.33 | 23.60 |
| 1″ | 63.23 (d, J = 5.2) | CH2 | 4.08, dt (7.4, 5.0) | 3.17 | 41.78 |
| 2″ | 41.78 (d, J = 6.6) | CH2 | 3.17, t (5.0) | 4.08 | 63.23 |
1D and 2D NMR spectral data (δ in ppm) of compound 11
| Position | 13C | DEPT, HMQC | δH, mult (J in Hz) | COSY | HMBC |
|---|---|---|---|---|---|
| 1 | 65.52 | CH2 | 4.06, dd (11.5, 6.0); | 4.15; 3.94 | 68.54; 174.31 |
| 4.15, dd (11.5, 4.7) | 4.06; 3.94 | ||||
| 2 | 68.54 | CH | 3.94, quint (5.4) | 3.46; 3.51 | 65.52; 170.75 |
| 3 | 72.35 | CH2 | 3.46, dd (10.5, 4.6) | 3.51; 3.94 | 68.54 |
| 3.51, dd (10.5, 5.6) | 3.46; 3.94 | ||||
| 1′ | 174.31 | C | |||
| 2′ | 33.94 | CH2 | 2.34, t (7.5) | 1.61 | 25.0; 174.31 |
| 3′ | 25.0 | CH2 | 1.61, m | 2.34; 1.32 | 33.94; 29.70 |
| 4′ | 29.16 | CH2 | 1.30–1.35 | 1.35–1.29; 1.61; 2.05 | 25.0–29.70 |
| 5′ | 29.19 | CH2 | |||
| 6′ | 29.29 | CH2 | |||
| 7′ | 29.7 | CH2 | |||
| 8′ | 27.17 | CH2 | 2.05, m | 1.35; 5.35 | 129.87/129.96; 29.16/29.19 |
| 9′ | 129.96 | CH | 5.35, m | 2.05 | 27.17 |
| 10′ | 128.13 | CH | 5.31, m | 2.76 | 25.56 |
| 11′ | 25.56 | CH2 | 2.76, t (6.6) | 5.31 | 128.06/128.13 |
| 12′ | 128.06 | CH | 5.31, m | 2.76 | 25.56 |
| 13′ | 129.87 | CH | 5.35, m | 2.05 | 27.17 |
| 14′ | 27.17 | CH2 | 2.05, m | 1.35; 5.35 | 129.87/129.96; 29.16/29.19 |
| 15′ | 29.46 | CH2 | 1.30–1.35 | 1.35–1.29; 1.61; 2.05 | 25.0–29.70 |
| 16′ | 31.64 | CH2 | |||
| 17′ | 22.6 | CH2 | 1.31, m | 0.9 | 13.48 |
| 18′ | 13.48 | CH3 | 0.90, t (6.5) | 1.31 | 22.60; 31.64 |
| 1″ | 170.75 | C | |||
| 2″ | 76.67 | CH | 3.75, dd (11.2, 2.6) | 2.07 | 170.75; 28.03; 51.04 |
| 3″ | 28.03 | CH2 | 2.07, m; | 2.23; 3.75 | 76.67; 67.55 |
| 2.23, m | 2.07; 3.55; 3.65 | ||||
| 4″ | 67.55 | CH2 | 3.55, m; | 3.65; 2.23; 2.07 | 76.67 |
| 3.65, m | 3.55; 2.23; 2.07 | ||||
| 5–7″ | 51.41 | 3CH3 | 3.20, s | 76.67 |
Fig. 3Antibacterial and antifungal activities of compounds 6 and 7. The mean diameter of inhibition zones resulting from the antimicrobial activities of compounds 6 and 7. a1 Results of compound 6 against C. albicans. b1 Results of compound 6 against E. coli. a2 Results of compound 7 against C. albicans. b2 Results of compound 7 against E. coli
Fig. 4Antiaging activities of compound 11. a Effect of compound 11 on lifespan of C. elegans (Control, equal volume solvent). b Effect of compound 11 on reproduction of C. elegans (Control, equal volume solvent). c Effect of compound 11 on locomotion (Control, equal volume solvent). d Effect of compound 11 on heat stress tolerance of C. elegans (Control, equal volume solvent)